ISH(In Situ Hybridization) 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 제공 제품별, 기술별, 용도별, 최종 사용자별, 지역별, 시장 예측(2025-2034년)

In Situ Hybridization Market Size, Share, Trends, & Industry Analysis Report By Offering (Consumables, Instruments, and Services & Software), By Technology, By Application, By End User, and By Region - Market Forecast, 2025-2034

US $ 4,250 ￦ 5,970,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250 ￦ 7,375,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250 ￦ 8,780,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Polaris Market Research의 최근 조사에 따르면 ISH(In Situ Hybridization) 시장 규모는 2034년까지 30억 1,557만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

ISH(In Situ Hybridization)는 조직 구조 내에서 유전자 발현 및 염색체의 특징을 직접 분석할 수 있기 때문에 임상 및 연구 환경 전반에 걸쳐 지속적으로 지원됩니다. 암 임상시험, 병리학, 유전학 등의 분야에서 이용이 확대되고 있는 것은 진단이나 치료 계획에 유전물질의 정확한 공간 매핑이 불가결한 암, 희소질환의 유전자 검사, 감염증 등의 유병률 증가가 배경에 있습니다.

프로브 라벨링, 디지털 이미징, 시스템 자동화의 최근 발전은 ISH 워크플로우의 감도와 확장성을 현저하게 향상시켰습니다. FISH와 같은 형광 기반 기술의 출현과 이미지 분석을 위한 인공지능의 통합은 검사실이 진단 정확도를 높이고, 소요 시간을 단축하며, 높은 처리량 샘플 평가를 지원하는 데 도움이 됩니다.

ISH(In Situ Hybridization) 시장 보고서 하이라이트

용도별로는 임상 진단 분야가 2024년 시장을 리드했습니다. 암과 같은 만성 질환의 유병률이 상승하고 정확한 조기 발견법에 대한 수요가 높아지고 있는 것이 배경에 있습니다.

최종 사용자별로 복잡한 분자 생물학 서비스의 아웃소싱 증가로 인해 계약 연구 기관(CRO)이 가장 빠르게 성장할 것으로 예측됩니다.

북미는 첨단 헬스케어 인프라와 확립된 진단 능력에 힘입어 2024년 최대 판매 점유율을 차지했습니다.

아시아태평양 시장은 생명 과학 연구 및 분자진단 인프라 개발 투자 증가로 인해 가장 빠른 속도로 확대될 것으로 예측됩니다.

세계의 주요 시장 업체는 Abbott Laboratories, Inc., Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Inc., Bio-Techne Corporation, BioCare Medical, LLC, BioGenex Laboratories, Inc., Bio-Rad Laboratories, Inc., BioView Ltd., F. Hoffmann-La Roche Ltd 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 ISH(In Situ Hybridization) 시장 인사이트

• 시장 현황
• ISH(In Situ Hybridization) 시장 역학
  • 성장 촉진요인 및 기회
    • 암과 유전성 질환의 발생률 상승
    • 분자진단 기술의 진보
  • 성장 억제요인 및 과제
    • 기기 및 시약의 고비용
    • 절차의 복잡성
• PESTEL 분석
• ISH(In Situ Hybridization) 시장 동향
• 밸류체인 분석

제5장 세계의 ISH(In Situ Hybridization) 시장 : 제공별

• 주요 조사 결과
• 서문
• 소모품
• 기기
• 서비스 및 소프트웨어

제6장 세계의 ISH(In Situ Hybridization) 시장 : 기술별

• 주요 조사 결과
• 서문
• 형광 ISH(In Situ Hybridization)(FISH)
• 크로모제닉 ISH(In Situ Hybridization)(CISH)

제7장 세계의 ISH(In Situ Hybridization) 시장 : 용도별

• 주요 조사 결과
• 서문
• 임상 진단
• 연구 용도
• 의약품 발견 및 개발

제8장 세계의 ISH(In Situ Hybridization) 시장 : 최종 사용자별

• 주요 조사 결과
• 서문
• 제약 및 바이오테크놀러지 기업
• 병원 및 진단실험실
• 학술연구기관
• 수탁연구기관

제9장 세계의 ISH(In Situ Hybridization) 시장 : 지역별

• 주요 조사 결과
• 서문
  • ISH(In Situ Hybridization) 시장 평가 : 지역별(2020-2034년)
• 북미
  • 북미 : 제공 제품별(2020-2034년)
  • 북미 : 기술별(2020-2034년)
  • 북미 : 용도별(2020-2034년)
  • 북미 : 최종 사용자별(2020-2034년)
  • 미국
  • 캐나다
• 유럽
  • 유럽 : 제공 제품별(2020-2034년)
  • 유럽 : 기술별(2020-2034년)
  • 유럽 : 용도별(2020-2034년)
  • 유럽 : 최종 사용자별(2020-2034년)
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 스페인
  • 네덜란드
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 아시아태평양 : 제공 제품별(2020-2034년)
  • 아시아태평양 : 기술별(2020-2034년)
  • 아시아태평양 : 용도별(2020-2034년)
  • 아시아태평양 : 최종 사용자별(2020-2034년)
  • 중국
  • 인도
  • 말레이시아
  • 일본
  • 인도네시아
  • 한국
  • 호주
  • 기타 아시아태평양
• 중동 및 아프리카
  • 중동 및 아프리카 : 제공 제품별(2020-2034년)
  • 중동 및 아프리카 : 기술별(2020-2034년)
  • 중동 및 아프리카 : 용도별(2020-2034년)
  • 중동 및 아프리카 : 최종 사용자별(2020-2034년)
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 남아프리카
  • 기타 중동 및 아프리카
• 라틴아메리카
  • 라틴아메리카 : 제공 제품별(2020-2034년)
  • 라틴아메리카 : 기술별(2020-2034년)
  • 라틴아메리카 : 용도별(2020-2034년)
  • 라틴아메리카 : 최종 사용자별(2020-2034년)
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타 라틴아메리카

제10장 경쟁 구도

• 확대 및 인수 분석
  • 확대
  • 인수
• 제휴, 협업, 합의 및 공개

제11장 기업 프로파일

• Abbott Laboratories, Inc.
• Advanced Cell Diagnostics, Inc.
• Agilent Technologies, Inc.
• Bio SB, Inc.
• Bio-Techne Corporation
• BioCare Medical, LLC
• BioGenex Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• BioView Ltd.
• F. Hoffmann-La Roche Ltd.
• Genemed Biotechnologies, Inc.
• Leica Biosystems Nussloch GmbH

AJY

영문 목차

영문목차

The in situ hybridization market size is expected to reach USD 3,015.57 Million by 2034, according to a new study by Polaris Market Research. The report "In Situ Hybridization Market Size, Share, Trends, & Industry Analysis Report By Offering (Consumables, Instruments, and Services & Software), By Technology, By Application, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

In situ hybridization (ISH) continues to gain traction across clinical and research environments due to its capability to analyze gene expression and chromosomal features directly within tissue architecture. Its expanding use in fields such as oncology clinical trials, pathology, and genetics is supported by the growing prevalence of cancer, rare disease genetic testing, and infectious conditions where accurate spatial mapping of genetic material is essential for diagnosis and treatment planning.

Recent advancements in probe labeling, digital imaging, and system automation have significantly improved the sensitivity and scalability of ISH workflows. The emergence of fluorescence-based techniques such as FISH and the integration of artificial intelligence for image analysis are helping laboratories enhance diagnostic precision, reduce turnaround times, and support high-throughput sample evaluation.

In Situ Hybridization Market Report Highlights

In terms of application, the clinical diagnostics segment led the market in 2024, driven by rising prevalence of chronic diseases like cancer and growing demand for accurate early detection methods.

Based on end user, the contract research organizations (CROs) are expected to grow the fastest, benefiting from increased outsourcing of complex molecular biology services.

North America held the largest revenue share in 2024, supported by its advanced healthcare infrastructure and established diagnostic capabilities.

The Asia Pacific market is anticipated to expand at the fastest rate, fueled by growing investments in life sciences research and molecular diagnostics infrastructure development.

A few global key market players include Abbott Laboratories, Inc., Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Inc., Bio-Techne Corporation, BioCare Medical, LLC, BioGenex Laboratories, Inc., Bio-Rad Laboratories, Inc., BioView Ltd., F. Hoffmann-La Roche Ltd.

Polaris Market Research has segmented the market report on the basis of offering, technology, application, end user, and region:

By Offering Outlook (Revenue, USD Million, 2020-2034)

Consumables

Instruments

Services & Software

By Technology Outlook (Revenue, USD Million, 2020-2034)

Fluorescent In Situ Hybridization (Fish)

Chromogenic In Situ Hybridization (Cish)

By Application Outlook (Revenue, USD Million, 2020-2034)

Clinical Diagnostics

Research Applications

Drug Discovery & Development

By End User Outlook (Revenue, USD Million, 2020-2034)

Pharmaceutical & Biotechnology Companies

Hospitals & Diagnostic Laboratories

Academic & Research Institutes

Contract Research Organizations

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global In Situ Hybridization Market Insights

• 4.1. In Situ Hybridization Market - Market Snapshot
• 4.2. In Situ Hybridization Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Incidence of Cancer and Genetic Disorders
    • 4.2.1.2. Advancements in Molecular Diagnostic Technologies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Cost of Equipment and Reagents
    • 4.2.2.2. Complexity of Procedures
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. In Situ Hybridization Market Trends
• 4.6. Value Chain Analysis

5. Global In Situ Hybridization Market, by Offering

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
• 5.3. Consumables
  • 5.3.1. Global In Situ Hybridization Market, by Consumables, by Region, 2020-2034 (USD Million)
• 5.4. Instruments
  • 5.4.1.1. Global In Situ Hybridization Market, by Instruments, by Region, 2020-2034 (USD Million)
  • 5.4.2. Global In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
• 5.5. Services & Software
  • 5.5.1. Global In Situ Hybridization Market, by Services & Software, by Region, 2020-2034 (USD Million)

6. Global In Situ Hybridization Market, by Technology

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
• 6.3. Fluorescent In Situ Hybridization (Fish)
  • 6.3.1. Global In Situ Hybridization Market, by Fluorescent In Situ Hybridization (Fish), by Region, 2020-2034 (USD Million)
• 6.4. Chromogenic In Situ Hybridization (Cish)
  • 6.4.1. Global In Situ Hybridization Market, by Chromogenic In Situ Hybridization (Cish), by Region, 2020-2034 (USD Million)

7. Global In Situ Hybridization Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
• 7.3. Clinical Diagnostics
  • 7.3.1. Global In Situ Hybridization Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Million)
• 7.4. Research Applications
  • 7.4.1. Global In Situ Hybridization Market, by Research Applications, by Region, 2020-2034 (USD Million)
• 7.5. Drug Discovery & Development
  • 7.5.1. Global In Situ Hybridization Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Million)

8. Global In Situ Hybridization Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
• 8.3. Pharmaceutical & Biotechnology Companies
  • 8.3.1. Global In Situ Hybridization Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
• 8.4. Hospitals & Diagnostic Laboratories
  • 8.4.1. Global In Situ Hybridization Market, by Hospitals & Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
• 8.5. Academic & Research Institutes
  • 8.5.1. Global In Situ Hybridization Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Million)
• 8.6. Contract Research Organizations
  • 8.6.1. Global In Situ Hybridization Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)

9. Global In Situ Hybridization Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. In Situ Hybridization Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. In Situ Hybridization Market - North America
  • 9.3.1. North America: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
  • 9.3.2. North America: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
  • 9.3.3. North America: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
  • 9.3.4. North America: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.3.5. In Situ Hybridization Market - U.S.
    • 9.3.5.1. U.S.: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.3.5.2. U.S.: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.3.5.3. U.S.: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.3.5.4. U.S.: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.3.6. In Situ Hybridization Market - Canada
    • 9.3.6.1. Canada: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
• 9.4. In Situ Hybridization Market - Europe
  • 9.4.1. Europe: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
  • 9.4.2. Europe: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
  • 9.4.3. Europe: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
  • 9.4.4. Europe: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.5. In Situ Hybridization Market - UK
    • 9.4.5.1. UK: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.5.2. UK: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.5.3. UK: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.5.4. UK: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.6. In Situ Hybridization Market - France
    • 9.4.6.1. France: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.6.2. France: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.6.3. France: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.6.4. France: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.7. In Situ Hybridization Market - Germany
    • 9.4.7.1. Germany: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.8. In Situ Hybridization Market - Italy
    • 9.4.8.1. Italy: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.9. In Situ Hybridization Market - Spain
    • 9.4.9.1. Spain: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.10. In Situ Hybridization Market - Netherlands
    • 9.4.10.1. Netherlands: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.11. In Situ Hybridization Market - Russia
    • 9.4.11.1. Russia: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.4.12. In Situ Hybridization Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
• 9.5. In Situ Hybridization Market - Asia Pacific
  • 9.5.1. Asia Pacific: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.5. In Situ Hybridization Market - China
    • 9.5.5.1. China: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.5.2. China: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.5.3. China: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.5.4. China: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.6. In Situ Hybridization Market - India
    • 9.5.6.1. India: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.6.2. India: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.6.3. India: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.6.4. India: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.7. In Situ Hybridization Market - Malaysia
    • 9.5.7.1. Malaysia: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.8. In Situ Hybridization Market - Japan
    • 9.5.8.1. Japan: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.9. In Situ Hybridization Market - Indonesia
    • 9.5.9.1. Indonesia: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.10. In Situ Hybridization Market - South Korea
    • 9.5.10.1. South Korea: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.11. In Situ Hybridization Market - Australia
    • 9.5.11.1. Australia: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.5.12. In Situ Hybridization Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
• 9.6. In Situ Hybridization Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.6.5. In Situ Hybridization Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.6.6. In Situ Hybridization Market - UAE
    • 9.6.6.1. UAE: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.6.7. In Situ Hybridization Market - Israel
    • 9.6.7.1. Israel: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.6.8. In Situ Hybridization Market - South Africa
    • 9.6.8.1. South Africa: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.6.9. In Situ Hybridization Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
• 9.7. In Situ Hybridization Market - Latin America
  • 9.7.1. Latin America: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
  • 9.7.2. Latin America: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
  • 9.7.3. Latin America: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
  • 9.7.4. Latin America: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.7.5. In Situ Hybridization Market - Mexico
    • 9.7.5.1. Mexico: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.7.6. In Situ Hybridization Market - Brazil
    • 9.7.6.1. Brazil: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.7.7. In Situ Hybridization Market - Argentina
    • 9.7.7.1. Argentina: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)
  • 9.7.8. In Situ Hybridization Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: In Situ Hybridization Market, by Offering, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: In Situ Hybridization Market, by Technology, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: In Situ Hybridization Market, by Application, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: In Situ Hybridization Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories, Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Advanced Cell Diagnostics, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Agilent Technologies, Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bio SB, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Bio-Techne Corporation
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. BioCare Medical, LLC
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. BioGenex Laboratories, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Bio-Rad Laboratories, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. BioView Ltd.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. F. Hoffmann-La Roche Ltd.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Genemed Biotechnologies, Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Leica Biosystems Nussloch GmbH
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development

관련자료